Chronic Graft Versus Host Disease (cGvHD)Symptoms, Doctors, Treatments, Advances & More
Chronic Graft Versus Host Disease (cGvHD) Overview
Save information for later
Sign Up
Learn About Chronic Graft Versus Host Disease (cGvHD)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Who are the top Chronic Graft Versus Host Disease (cGvHD) Local Doctors?
Learn More
What are the Latest Advances for Chronic Graft Versus Host Disease (cGvHD)?
Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation.
Journal: Cell transplantation
Published: April 04, 2026
Alpha 1 Antitrypsin Suppresses Autoantibody Production and Cellular Autoimmunity in Chronic Graft-Versus-Host Disease (cGVHD) in a Lupus Mouse Model.
Journal: Biomolecules
Published: January 28, 2026
Tired of the same old research?
Check Latest Advances
Ruxolitinib as a Steroid-Sparing Treatment for Chronic Graft vs Host Disease.
Journal: Transplantation and cellular therapy
Published: January 14, 2026
What are the latest Chronic Graft Versus Host Disease (cGvHD) Clinical Trials?